Researchers learn why carp virus inhibits host cell immune system
September 26, 2022 -- Belgian researchers have learned how a carp virus uses the protein domain Zalpha (Zα) to inhibit the defense mechanisms of the host cell. The discovery has implications for how Zα domain-containing proteins of the immune system function. Read More
Zebrafish help scientists understand organ regeneration
September 20, 2022 -- Researchers from the Stowers Institute for Medical Research are using zebrafish to investigate how their immune systems repair and regenerate organs. The findings could potentially help alleviate human conditions that might otherwise require organ transplants and lifelong immunosuppressants. Read More
Cow mucus-derived lubricant stops HIV, herpes in lab tests
September 19, 2022 -- A synthetic prophylactic gel based on cow mucus is 70% effective against HIV and 80% effective against herpes in lab tests, a new study reveals. Read More
NCI awards $13.3M for cancer research on drug sequencing
September 15, 2022 -- The National Cancer Institute (NCI) awarded a five-year, $13.3 million grant to a team of researchers to study sequential combinations of targeted inhibitors and immunotherapies for cancer. Read More
Scientists decrease IBD inflammation with specific protein
September 15, 2022 -- How a set of molecules interact with each other in gut immune cells could prevent the inflammation seen in inflammatory bowel diseases (IBDs), according to University of Texas Southwestern researchers. The findings suggest a new drug target for treating IBD and related conditions. Read More
Federal funding of $2B to support biotechnology and biomanufacturing
September 14, 2022 -- The White House announced on Wednesday federal funding of more than $2 billion to advance President Joe Biden’s executive order intended to enable the U.S. to harness the full potential of biotechnology and biomanufacturing. Read More
Discovery of toxin that kills bacteria could pave way for new antibiotics
September 6, 2022 -- McMaster University researchers have discovered a previously unknown bacteria-killing toxin that has the potential to be exploited for future antibiotic development to combat infection-causing bacteria. Read More
New treatment from Sweden for hepatitis B, D shows promise in mice
August 29, 2022 -- Researchers at Karolinska Institutet in Sweden have developed a new type of treatment for chronic hepatitis B virus and hepatitis D virus infections that may provide a lasting treatment response. Read More
Bio-Rad offers antievolocumab antibodies for preclinical, clinical drug development
August 25, 2022 -- Bio-Rad Laboratories is now offering a range of antievolocumab antibodies approved for in vitro research purposes and for commercial in vitro testing services to support preclinical and clinical drug development. Read More
NSF awards $6M to develop purification membranes for large-scale manufacturing of viral vectors
August 19, 2022 -- The National Science Foundation (NSF) has awarded a $6 million grant to researchers at the University of Arkansas and two partner institutions to develop purification membranes for future large-scale manufacturing of viral vectors and viruslike particles. Read More
Conferences
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
